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ABSTRACT 
Starch glutamate was a novel superdisintegrant which was synthesized from the native potato starch and glutamic acid by esterification 
process. The prepared starch glutamate toxicity was evaluated by performing acute and sub-acute toxicity studies on the Wister rats and Swiss 
albino mice. Acute toxicity studies were conducted on the Swiss albino mice by dividing them randomly into 10 groups (6 rats in each group) 
and treated with starch glutamate up to the concentration of 2000mg/Kg body weight, and then they were closely observed for 12 hrs for any 
toxic symptoms. Sub –acute toxicity studies were performed on the Wister rats by dividing them into 5 groups (6 rats in each group) and 
treating them with starch glutamate up to the concentration of 2000mg/Kg body weight once daily for 28 days and on 29th day animals were 
sacrificed and blood samples were analysed for change in haematological parameters and biochemical parameters. The prepared starch 
glutamate was safe up to the concentration of 2000mg/Kg body weight and it did not exhibit any change in the haematological parameters and 
bio-chemical parameters. 
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INTRODUCTION 
Superdisintegrants are the substances which were added to 
the fast dissolving tablets to improve the disintegration 
process of the tablet. Superdisintegrants were added to the 
formulation at a lower concentration typically 1-10% by 
weight relative to the total weight of the dosage form to fast 
up the disintegration process. Superdisintegrants can be 
divided into natural superdisintegrants and synthetic 
superdisintegrants. Whether the superdisintegrnat obtained 
from the plant origin or synthesized in laboratory it is 
necessary to screen its toxicity data. Toxicity studies1 will be 
conducted to know the adverse effects of a substance on 
human or animal health or on environment. Toxicity can be 
divided into acute toxicity, sub-acute toxicity and chronic 
toxicity. Acute toxicity defined as adverse effects occurred 
within a short period of time after administration of a single 
oral dose of a substance or multiple doses given within 24 
hours. Sub-acute toxicity can be defined as an occurrence of 
adverse effects due to continuous or multiple exposures 
between 24h and 28days. 
In the present study, a new superdisintegrant starch 
glutamate was synthesized from the native potato starch by 
esterification process. Toxicity studies have been performed 
for the starch glutamate on Wister rats and Swiss albino mice 
to identify the safe concentration of it in the formulation of 
dosage forms. 
MATERIALS AND METHODS: 
Materials: 
Glutamic acid, potato starch, acetone, hydrochloric acid, 
potassium di hydrogen phosphate, dimethyl sulfoxide 
procured from the SD Fine chemicals. Mercuric chloride, 
Sodium chloride, Glacial acetic acid, Ammonium oxalate, 
Sodium hydrogen phosphate, Potassium dihydrogen 
phosphate purchaged from Merck, Mumbai. Crystalline 
sodium sulphate, Ethanol, Gentian violet, Wrights stain, 
Methanol from Qualigens Fine Chemicals, Mumbai. Merck 
analytical kit. 
Preparation of Starch Glutamate: 
10 parts of potato starch and 10 parts of glutamic acid were 
accurately weighed. 10 parts of previously weighed potato 
starch was dispersed into 25 parts of distilled water to make 
starch slurry.10parts of glutamic acid was dissolved in 
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distilled water and then it was added to the starch slurry. pH 
of the dispersion (Glutamic acid and starch slurry) was 
adjusted to 3.5 by adding 10ml of sodium hydroxide, then it 
was conditioned for 16hr to complete the reaction between 
potato starch and glutamic acid. After conditioning, 
unreacted glutamic acid was removed by washing this 
dispersion with distilled water, and then this solid mass was 
dried at 60°C temperature to form starch glutamate. The 
dried starch glutamate was passed through #120 sieve to 
obtain uniform sized particle and stored in a desiccator. 
Toxicity Studies of Starch Glutamate : 
Toxicity of prepared starch glutamate was evaluated by 
performing acute, sub-acute and chronic toxicity studies. 
Toxicity studies of starch glutamate on animals were 
approved by the Institutional Animal Ethical Committee, 
GITAM Institute of Pharmacy, GITAM (Deemed to be 
University), and Visakhapatnam (Approval No: 
1287/PO/Re/S/09/CPCSEA). 
Animal Housing 2: 
The animals (Wister rats and Swiss albino mice) were 
housed in a stainless steel cages which containing automatic 
watering system. Six Wister rats were placed in one cage, 
where as one Swiss albino mice were placed in separate 
cages. All these animals were maintained in a clean room, 
with temperature as 68-76°F and humidity as 42%-72% 
respectively. These animals were allowed to expose for 12hr 
complete light and dark cycles in a day. 
Acute Toxicity Studies: 
Swiss albino rats were selected as an animal model to 
conduct acute toxicity studies. Swiss albino rats weighing 20-
25g of body weight of either sex were taken and divided into 
10 groups, each group containing 6rats. These rats were 
fastened overnight before conducting experiment. These 
Swiss albino rats were treated with starch glutamate through 
oral route with distilled water at four levels i.e. 50, 300, 1000 
& 2000mg/Kg of body weight3 and these were closely 
observed for 12hr for any toxicity symptoms4 like increased 
motor activity, anesthesia, tremors, arching and rolling, 
chronic convulsions, ptosis, tonic extension, lacrimation, 
straub reactions, exophthalmos, pilo-erection, salivation, 
muscle spasm, opisthotonus, writhing, hyperthesia, loss on 
righting reflex, depression, ataxia, stimulation, sedation, 
blanching, hypnosis, cyanosis, analgesia and for 12h 
mortality rate. 
Sub –Acute Toxicity Studies 5: 
In sub-acute toxicity studies, Wister rats of either sex 
containing a body weight of 130-150g were selected. These 
Wister rats were randomly selected and divided into 5 
groups, each group containing 6 rats. Group-I selected as a 
control group, which was treated with distilled water for 28 
days once in a day. Group-II received 50mg/Kg of starch 
glutamate once in a day for 28days, Group-III received 
300mg/Kg starch glutamate once in a day for 28days, Group-
IV received 100mg/Kg starch glutamate once in a day for 28 
days, and Group-V received 2000mg/Kg starch glutamate 
once in a day for 28days. All the animals were monitored for 
food intake, water intake and body weight for 28days on 
weekly basis. Animals were sacrificed on 29th day and blood 
samples were collected and various organs like liver, kidney 
and heart were isolated and weighed. 
Blood samples were analysed to know the changes in the 
haematological parameter like haemoglobin (Hb), red blood 
cell (RBC) count , white blood cell count (WBC) , erythrocyte 
sedimentation rate (ESR), differential count (DC) 
[neutrophils (N)], lymphocytes (L) , eosinophils (E), 
monocytes (M),  and basophils (B) as well as changes in the 
biochemical parameters like serum glutamate oxaloacetate 
transaminase (SGOT), serum glutamate pyruvate 
transaminase (SGPT), alkaline phosphatase (ALP), bilirubin, 
blood urea nitrogen (BUN) and serum creatinine.  
Statistical Analysis 6: 
One way analysis of variance (ANOVA) and dunnetts test was 
used to calculate the results of acute and sub-acute toxicity 
studies. 
RESULTS AND DISCUSSIONS: 
Acute Toxicity Studies: 
In acute toxicity studies Swiss albino mice, which were 
received up to the dose of 2000mg/Kg body weight of starch 
glutamate did not show any lethal effects and toxicity 
symptoms like increased motor activity, anaesthesia, 
tremors, arching and rolling, chronic convulsions, ptosis, 
tonic extension, lacrimation, straub reactions, exophthalmos, 
pilo-erection, salivation, muscle spasm, opisthotonus, 
writhing, hyperthesia, loss on righting reflex, depression, 
ataxia, stimulation, sedation, blanching, hypnosis, cyanosis, 
analgesia. From the acute toxicity results it was concluded 
that the prepared starch glutamate was non-toxic and safe 
up to the dose of 2000mg/Kg body weight and its LD50 could 
be greater than 2000mg/Kg body weight. 
Sub-Acute Toxicity Studies: 
In sub-acute toxicity studies Wister rats were received starch 
glutamate up to the dose of 2000mg/Kg body weight once in 
a day for 28 days. These rats were monitored for 28 days on 
weekly basis for change in increment in body weight and 
results were tabulated in following Table 1. 
 
Table 1: Effect of Starch Glutamate on Body Weight Increment in 28days Treatment 
 
Group 
Body Weight in grams, n= 6 
Mean ± S.E 
Initial 1st  week 2nd  week 3rd week 4th week 
I 145 ± 1.4 147 ± 1.3 149 ± 1.1 150 ± 0.8 152 ± 1.2 
II. 138 ± 1.1ns 140 ± 0.8ns 142 ± 1.1ns 144 ± 1.2ns 146 ± 1.1ns 
III 139 ± 1.2ns 141 ± 1.3ns 143 ± 1.2ns 144 ± 0.3ns 145 ± 0.4ns 
IV 142 ± 1.0ns 144 ± 1.1ns 147 ± 1.4ns 148 ± 1.1ns 149 ± 0.5ns 
V 144 ± 1.1ns 146 ± 1.2ns 148 ± 1.2ns 149 ± 1.2ns 151 ± 1.2ns 
        ns: non-significance 
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In the sub-acute toxicity study, starch glutamate treated 
groups did not show any significant changes in body 
increment in weekly intervals compared to that control 
group. 
Organs which were isolated from the sacrificed rats after 28 
days were weighed for increment in weight of organs like 
liver, kidney and heart. The results were tabulated in the 
Table 2. From the results, it was concluded that the weights 
of the liver, kidney and heart were unaltered in the 
experimental groups compared with control group.
 
 
Table 2: Effect of 28 Days Oral Administration of Starch Glutamate on Organ Weights in Rats 
 
Group 
Organ weight (g/100 g body weight), n=6, mean ± S.E 
Liver Kidney Heart 
I        2.35 ± 1.0 0.65 ± 0.5 0.30 ± 0.1 
II 2.30 ± 1.1ns 0.58 ± 0.2ns 0.28 ± 0.2ns 
III 2.32 ± 1.2ns 0.60 ± 0.1ns 0.31 ± 0.1ns 
IV 2.48 ± 1.3ns 0.64 ± 0.4ns 0.28 ± 0.3ns 
V 2.55 ± 1.2ns 0.66 ± 0.7ns 0.31 ± 0.2ns 
 
Kidney functions in rats like blood urea and serum 
creatinine were studied after 28days of administration of 
starch glutamate. Results were tabulated in Table 3.From the 
result, it was concluded that starch glutamate treated group 
rats were did not show any significant changes in the kidney 
function when compared to the control group. 
 
Table 3:  Effect of 28 days administration of starch glutamate on kidney functions in rats 
Group Blood urea (mg%) Serum creatinine (mg/dL) 
I 40.21 ± 0.1 0.72 ± 0.2 
II 40.74 ± 0.2ns 0.71 ± 0.3ns 
III 40.35 ± 0.3ns 0.72 ± 0.4ns 
IV 40.44 ± 0.3ns 0.73 ± 0.6ns 
V 40.52 ± 0.3ns 0.74 ± 0.5ns 
 
Blood samples were analysed for changes in the 
haematological parameter and hepatic functions in rats and 
results were given in the Table 4 & 5. From these results, it 
was concluded that the there was no significant changes in 
the haematological parameters and hepatic parameters in 
starch glutamate treated groups when compared to 
controlled groups. 
 
Table 4: Effects of 28days Administration of Starch Glutamate on Haematological Parameters in Rats 
Group ESR(mm/h) Hb (%) RBC  
(X 106 
mm3) 
WBC 
(X 103 
mm3) 
Differential Count Percentage 
N L E M B 
I 6.51 ± 0.31 10.11±0.2 6.21±1.1 7.11±1.1 67.44±1.2 28.2±1.1 1.2±0.1 2.33±1.1 - 
II 6.01 ± 0.37ns 10.54±0.1ns 6.22±1.3ns 7.27±1.2ns 67.57±1.3ns 28.3±1.4ns 1.1±0.2ns 2.41±1.2ns - 
III 6.35 ± 0.78ns 10.22±0.3ns 6.31±1.2ns 7.34±1.4ns 67.26±1.1ns 28.5±1.3ns 1.3±0.2ns 2.37±1.2ns - 
IV 6.55 ± 0.32ns 10.12±0.4ns 6.21±1.4ns 7.40±1.2ns 67.74±1.3ns 28.2±1.2ns 1.2±0.3ns 2.26±1.3ns - 
V 6.66 ± 0.45ns 10.42±0.4ns 6.33±1.1ns 7.25±1.3ns 67.24±1.5ns 28.4±1.2ns 1.1±0.4ns 2.35±1.4ns - 
Data are the mean of 6 animals ± S.E, ESR: Erythrocyte sedimentation rate, Hb: Hemoglobin, RBC: Red blood cells, WBC: White 
blood cells, N: Neutrophils, L:-Lymphocytes, E: Eosinophils, M: Monocytes, B: Basophils, ns = non-significance 
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Table 5: Effects of 28days Administration of Starch Glutamate on Hepatic Functions in Rats 
Group Liver glycogen 
(mg%) 
SGPT 
(IU/L) 
SGOT 
(IU/L) 
ALP 
(IU/L) 
Bilirubin 
(mg/dL) 
I 135.3 ± 1.2 42.54 ± 1.2 115.74 ± 1.2 209.74 ± 1.2 0.73±0.12 
II 136.2 ± 1.3ns 42.74 ± 1.2ns 115.25 ± 1.3ns 209.58 ± 1.3ns 0.71±0.10ns 
III 137.5 ± 1.2ns 42.85 ± 1.1ns 115.22 ± 1.1ns 209.63 ± 1.7ns 0.73±0.12ns 
IV 137.4 ± 1.3ns 42.44 ± 1.2ns 115.74 ± 1.5ns 209.71 ± 1.5ns 0.74±0.15ns 
V 135.7 ±1.4ns 42.75 ± 1.3ns 115.86 ± 1.6ns 209.28± 1.6ns 0.75±0.14ns 
Data are the mean of 6 animals ± S.E, SGPT: Serum glutamate pyruvate transaminase, SGOT: Serum glutamate oxaloacetate 
transaminase, ALP: Alkaline phosphatase, ns:non-significance. 
 
CONCLUSION: 
Starch glutamate which was synthesised from the native 
potato starch by esterification process did not produce any 
adverse effects on the behaviour and gross pathology on the 
rats at treated doses. Therefore the oral LD50 of the starch 
glutamate was greater than the 2000mg/Kg. Sub-acute 
toxicity studies of starch glutamate also reveals that, it did 
not produce any adverse effects on the body weight, 
haematological, and biochemical parameters at test doses. 
There were no signs of toxicity was observed in the kidney, 
liver and heart sections of treated animals. From the toxicity 
studies of starch glutamate, it was concluded that it was safe 
and non-toxic up to the dose of 2000mg/Kg.Therefore, starch 
glutamate can be used as a superdisintegrant in the 
formulation of fast dissolving systems. 
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